These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8702626)

  • 1. Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein association.
    Holvoet P; Zhao Z; Deridder E; Dhoest A; Collen D
    J Biol Chem; 1996 Aug; 271(32):19395-401. PubMed ID: 8702626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Arg123-Tyr166 paired helix of apolipoprotein A-I in lecithin:cholesterol acyltransferase activation.
    Dhoest A; Zhao Z; De Geest B; Deridder E; Sillen A; Engelborghs Y; Collen D; Holvoet P
    J Biol Chem; 1997 Jun; 272(25):15967-72. PubMed ID: 9188498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to the carboxyl terminus of human apolipoprotein A-I. The putative cellular binding domain of high density lipoprotein 3 and carboxyl-terminal structural homology between apolipoproteins A-I and A-II.
    Allan CM; Fidge NH; Kanellos J
    J Biol Chem; 1992 Jul; 267(19):13257-61. PubMed ID: 1377682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein association of human apolipoprotein E/A-I chimeras. Expression in transfected hepatoma cells.
    Thurberg BL; Reardon CA; Getz GS
    J Biol Chem; 1996 Mar; 271(11):6062-70. PubMed ID: 8626391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II.
    Lagrost L; Dengremont C; Athias A; de Geitere C; Fruchart JC; Lallemant C; Gambert P; Castro G
    J Biol Chem; 1995 Jun; 270(22):13004-9. PubMed ID: 7768892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
    Laccotripe M; Makrides SC; Jonas A; Zannis VI
    J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the carboxy-terminal domain of human apolipoprotein AI in high-density-lipoprotein metabolism--a study based on deletion and substitution variants in transgenic mice.
    Holvoet P; Danloy S; Collen D
    Eur J Biochem; 1997 May; 245(3):642-7. PubMed ID: 9183000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroxine binding to the apolipoproteins of high density lipoproteins HDL2 and HDL3.
    Benvenga S; Cahnmann HJ; Rader D; Kindt M; Robbins J
    Endocrinology; 1992 Dec; 131(6):2805-11. PubMed ID: 1446618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of apolipoprotein A-II on the structure and function of apolipoprotein A-I in a homogeneous reconstituted high density lipoprotein particle.
    Durbin DM; Jonas A
    J Biol Chem; 1997 Dec; 272(50):31333-9. PubMed ID: 9395462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum opacity factor, a streptococcal virulence factor that binds to apolipoproteins A-I and A-II and disrupts high density lipoprotein structure.
    Courtney HS; Zhang YM; Frank MW; Rock CO
    J Biol Chem; 2006 Mar; 281(9):5515-21. PubMed ID: 16407233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I alpha -helices 7 and 8 modulate high density lipoprotein subclass distribution.
    Reschly EJ; Sorci-Thomas MG; Davidson WS; Meredith SC; Reardon CA; Getz GS
    J Biol Chem; 2002 Mar; 277(12):9645-54. PubMed ID: 11744719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.
    Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS
    J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of apolipoprotein A-I with high-density lipoprotein particles.
    Nguyen D; Nickel M; Mizuguchi C; Saito H; Lund-Katz S; Phillips MC
    Biochemistry; 2013 Mar; 52(11):1963-72. PubMed ID: 23425306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The specific amino acid sequence between helices 7 and 8 influences the binding specificity of human apolipoprotein A-I for high density lipoprotein (HDL) subclasses: a potential for HDL preferential generation.
    Carnemolla R; Ren X; Biswas TK; Meredith SC; Reardon CA; Wang J; Getz GS
    J Biol Chem; 2008 Jun; 283(23):15779-88. PubMed ID: 18385132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding.
    Liadaki KN; Liu T; Xu S; Ishida BY; Duchateaux PN; Krieger JP; Kane J; Krieger M; Zannis VI
    J Biol Chem; 2000 Jul; 275(28):21262-71. PubMed ID: 10801839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of apolipoprotein-specific high-density lipoprotein particles from lipid-free apolipoproteins A-I and A-II.
    Clay MA; Cehic DA; Pyle DH; Rye KA; Barter PJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):445-51. PubMed ID: 9895287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo studies of HDL assembly and metabolism using adenovirus-mediated transfer of ApoA-I mutants in ApoA-I-deficient mice.
    Reardon CA; Kan HY; Cabana V; Blachowicz L; Lukens JR; Wu Q; Liadaki K; Getz GS; Zannis VI
    Biochemistry; 2001 Nov; 40(45):13670-80. PubMed ID: 11695916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-II-mediated conformational changes of apolipoprotein A-I in discoidal high density lipoproteins.
    Gauthamadasa K; Vaitinadin NS; Dressman JL; Macha S; Homan R; Greis KD; Silva RA
    J Biol Chem; 2012 Mar; 287(10):7615-25. PubMed ID: 22235130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mutation in the human apolipoprotein A-I gene. Dominant effect on the level and characteristics of plasma high density lipoproteins.
    Deeb SS; Cheung MC; Peng RL; Wolf AC; Stern R; Albers JJ; Knopp RH
    J Biol Chem; 1991 Jul; 266(21):13654-60. PubMed ID: 1906882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carboxyl-terminal domain truncation alters apolipoprotein A-I in vivo catabolism.
    Schmidt HH; Remaley AT; Stonik JA; Ronan R; Wellmann A; Thomas F; Zech LA; Brewer HB; Hoeg JM
    J Biol Chem; 1995 Mar; 270(10):5469-75. PubMed ID: 7890663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.